Search research articles
Contact Us
Filters
Showing results (311-320 of 344) with videos related to
Page
of 35
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 18, 2020
Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial
K Kalinsky, J R Diamond, L T Vahdat, et al.
Scientific Data
|
November 1, 2019
7 Tesla MRI of the ex vivo human brain at 100 micron resolution
Brian L Edlow, Azma Mareyam, Andreas Horn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2021
A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation
Florence Atrafi, Oliver Boix, Vivek Subbiah, et al.
Cancer Chemotherapy and Pharmacology
|
February 26, 2021
A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers
Wen Wee Ma, Mojun Zhu, Elaine T Lam, et al.
BMC Cancer
|
October 30, 2022
ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer
S Lindsey Davis, Sarah J Hartman, Stacey M Bagby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2022
Correction: A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation
Florence Atrafi, Oliver Boix, Vivek Subbiah, et al.
Cancers
|
April 27, 2024
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors
S Lindsey Davis, Wells A Messersmith, W Thomas Purcell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2010
Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumors
Jennifer R Diamond, Bruno R Bastos, Ryan J Hansen, et al.
NPJ Breast Cancer
|
June 10, 2022
Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis
Lisa A Carey, Delphine Loirat, Kevin Punie, et al.
Journal for Immunotherapy of Cancer
|
February 10, 2019
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
A Capasso, J Lang, T M Pitts, et al.
Page
of 35
Search research articles
Search
Showing results (311-320 of 344) with videos related to
Sort By:
Page
of 35
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 18, 2020
Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial
K Kalinsky, J R Diamond, L T Vahdat, et al.
Scientific Data
|
November 1, 2019
7 Tesla MRI of the ex vivo human brain at 100 micron resolution
Brian L Edlow, Azma Mareyam, Andreas Horn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2021
A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation
Florence Atrafi, Oliver Boix, Vivek Subbiah, et al.
Cancer Chemotherapy and Pharmacology
|
February 26, 2021
A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers
Wen Wee Ma, Mojun Zhu, Elaine T Lam, et al.
BMC Cancer
|
October 30, 2022
ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer
S Lindsey Davis, Sarah J Hartman, Stacey M Bagby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2022
Correction: A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation
Florence Atrafi, Oliver Boix, Vivek Subbiah, et al.
Cancers
|
April 27, 2024
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors
S Lindsey Davis, Wells A Messersmith, W Thomas Purcell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2010
Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumors
Jennifer R Diamond, Bruno R Bastos, Ryan J Hansen, et al.
NPJ Breast Cancer
|
June 10, 2022
Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis
Lisa A Carey, Delphine Loirat, Kevin Punie, et al.
Journal for Immunotherapy of Cancer
|
February 10, 2019
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
A Capasso, J Lang, T M Pitts, et al.
Page
of 35